Emerging Diagnostic Technology Assists Clinical Laboratories in Faster, More Accurate Diagnoses

Innovative diagnostic technologies are being launched frequently, often making it difficult for clinical laboratory managers and pathologists to determine which new test has the most valuable clinical output, while simultaneously being able to command an adequate reimbursement by payers.  Additionally, each time a laboratory acquires a new medical laboratory testing capability, it requires substantial effort and funds to research, purchase, train, and educate physicians on the merit of the test.

Two specific areas of medicine that have been positively impacted by such new developments of medical laboratory tests include infectious diseases and oncology.  Rapid molecular testing makes it possible for labs to deliver accurate information back to the referring physician in a few hours, versus a few days for historical microbiology test procedures.  This has assisted in revolutionizing screening for cancers such as leukemia and breast cancer.

Emerging research on the accuracy of colon cancer screening tests suggest that the newer immunochemical screening tests (iFOBTs) that use antibodies to identify human blood in stool are more accurate than older screening tests based on just chemical reactions.

To help determine which medical testing equipment is appropriate to invest your laboratory resources in, and how best to automate your laboratory processes, contact Colaborate for medical laboratory automation consulting.

By Kevin Hunter